Showing results (481-490 of 531) with videos related to

Sort By:
Pageof 54
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2023
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapyMireia Uribe-Herranz, Silvia Beghi, Marco Ruella, et al.
Nature Biomedical Engineering|August 25, 2025
Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cellsTomasz M Grzywa, Alexandra Neeser, Ranjani Ramasubramanian, et al.
Communications Medicine|April 24, 2025
Distinct immune responses in people living with HIV following SARS-CoV-2 recoveryDieter Mielke, Shuying Sue Li, Daniel J Schuster, et al.
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
NEJM Evidence|May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2021
Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past Is Prologue" (Shakespeare)Anthony R Mato, Matthew S Davids, Jeff Sharman, et al.
Blood Advances|March 29, 2022
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemiaSaar Gill, Vanessa Vides, Noelle V Frey, et al.
Blood|September 8, 2016
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experienceAnthony R Mato, Chadi Nabhan, Paul M Barr, et al.
Blood Advances|December 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Luca Paruzzo, Jakub Svoboda, et al.
Pageof 54